Systemic sclerosis (SSc) is characterized by an abnormal immune response to innocuous antigens that might lead to autoantibody production. New observations suggest that nucleosomes can mediate both IgG production and B-cell proliferation, via Toll-like receptor signalling, and thereby affect the pathogenesis of SSc.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yoshizaki, A. et al. Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2015-207405 (2015).
Amoura, Z. et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus. Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum. 40, 2217–2225 (1997).
Magna, M. & Pisetsky, D. S. The role of cell death in the pathogenesis of SLE: is pyroptosis the missing link? Scand. J. Immunol. 82, 218–224 (2015).
Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).
Ciechomska, M., van Laar, J. & O'Reilly, S. Current frontiers in systemic sclerosis pathogenesis. Exp. Dermatol. 24, 401–406 (2015).
Fullard, N. & O'Reilly, S. Role of innate immune system in systemic sclerosis. Semin. Immunopathol. 37, 511–517 (2015).
O'Reilly, S., Ciechomska, M., Cant, R. & van Laar, J. M. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J. Biol. Chem. 289, 9952–9960 (2014).
Bosello, S.L. et al. Long term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis. Semin. Arthritis Rheum. 44, 428–436 (2015).
Ciechomska, M. et al. Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors. Ann. Rheum. Dis. 72, 1382–1389 (2013).
Balak, D.M.W. et al. http://www.iderapharma.com/wp-content/uploads/2015/11/imo-8400_psoriasis_aad_poster-final.pdf (2015).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
O'Reilly, S., van Laar, J. Nucleosomes and systemic sclerosis. Nat Rev Rheumatol 12, 138–139 (2016). https://doi.org/10.1038/nrrheum.2016.9
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2016.9